These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9860926)

  • 1. Multiple activated oxygen species in P450 catalysis: contributions To specificity in drug metabolism.
    Coon MJ; Vaz AD; McGinnity DF; Peng HM
    Drug Metab Dispos; 1998 Dec; 26(12):1190-3. PubMed ID: 9860926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ipso-substitution by cytochrome P450 with conversion of p-hydroxybenzene derivatives to hydroquinone: evidence for hydroperoxo-iron as the active oxygen species.
    Vatsis KP; Coon MJ
    Arch Biochem Biophys; 2002 Jan; 397(1):119-29. PubMed ID: 11747318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxo-iron and oxenoid-iron species as alternative oxygenating agents in cytochrome P450-catalyzed reactions: switching by threonine-302 to alanine mutagenesis of cytochrome P450 2B4.
    Vaz AD; Pernecky SJ; Raner GM; Coon MJ
    Proc Natl Acad Sci U S A; 1996 May; 93(10):4644-8. PubMed ID: 8643457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epoxidation of olefins by cytochrome P450: evidence from site-specific mutagenesis for hydroperoxo-iron as an electrophilic oxidant.
    Vaz AD; McGinnity DF; Coon MJ
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3555-60. PubMed ID: 9520404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly reactive electrophilic oxidants in cytochrome P450 catalysis.
    Newcomb M; Chandrasena RE
    Biochem Biophys Res Commun; 2005 Dec; 338(1):394-403. PubMed ID: 16168951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Models and mechanisms of O-O bond activation by cytochrome P450. A critical assessment of the potential role of multiple active intermediates in oxidative catalysis.
    Hlavica P
    Eur J Biochem; 2004 Nov; 271(22):4335-60. PubMed ID: 15560776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proton-shuttle mechanism mediated by the porphyrin in benzene hydroxylation by cytochrome p450 enzymes.
    de Visser SP; Shaik S
    J Am Chem Soc; 2003 Jun; 125(24):7413-24. PubMed ID: 12797816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrete species of activated oxygen yield different cytochrome P450 heme adducts from aldehydes.
    Kuo CL; Raner GM; Vaz AD; Coon MJ
    Biochemistry; 1999 Aug; 38(32):10511-8. PubMed ID: 10441147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic isotope effects implicate two electrophilic oxidants in cytochrome p450-catalyzed hydroxylations.
    Newcomb M; Aebisher D; Shen R; Chandrasena RE; Hollenberg PF; Coon MJ
    J Am Chem Soc; 2003 May; 125(20):6064-5. PubMed ID: 12785830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative deboronation of the peptide boronic acid proteasome inhibitor bortezomib: contributions from reactive oxygen species in this novel cytochrome P450 reaction.
    Labutti J; Parsons I; Huang R; Miwa G; Gan LS; Daniels JS
    Chem Res Toxicol; 2006 Apr; 19(4):539-46. PubMed ID: 16608165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxo-iron mediated deformylation in sterol 14alpha-demethylase catalysis.
    Sen K; Hackett JC
    J Am Chem Soc; 2010 Aug; 132(30):10293-305. PubMed ID: 20662512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EPR spectrometry of cytochrome P450 2B4: effects of mutations and substrate binding.
    LeLean JE; Moon N; Dunham WR; Coon MJ
    Biochem Biophys Res Commun; 2000 Sep; 276(2):762-6. PubMed ID: 11027544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple oxidants in cytochrome P450 catalyzed reactions: implications for drug metabolism.
    Vaz AD
    Curr Drug Metab; 2001 Mar; 2(1):1-16. PubMed ID: 11465148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of a novel reversible cytochrome P450 spectral intermediate: role of threonine 303 in P450 2E1 inactivation.
    Blobaum AL; Lu Y; Kent UM; Wang S; Hollenberg PF
    Biochemistry; 2004 Sep; 43(38):11942-52. PubMed ID: 15379534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of deuterium isotope effects to probe the active site properties, mechanism of cytochrome P450-catalyzed reactions, and mechanisms of metabolically dependent toxicity.
    Nelson SD; Trager WF
    Drug Metab Dispos; 2003 Dec; 31(12):1481-98. PubMed ID: 14625345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compound lipophilicity for substrate binding to human P450s in drug metabolism.
    Lewis DF; Jacobs MN; Dickins M
    Drug Discov Today; 2004 Jun; 9(12):530-7. PubMed ID: 15183161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic deuterium isotope effects for 7-alkoxycoumarin O-dealkylation reactions catalyzed by human cytochromes P450 and in liver microsomes. Rate-limiting C-H bond breaking in cytochrome P450 1A2 substrate oxidation.
    Kim KH; Isin EM; Yun CH; Kim DH; Guengerich FP
    FEBS J; 2006 May; 273(10):2223-31. PubMed ID: 16649998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the conserved threonine in P450 BM3 oxygen activation: substrate-determined hydroxylation activity of the Thr268Ala mutant.
    Cryle MJ; De Voss JJ
    Chembiochem; 2008 Jan; 9(2):261-6. PubMed ID: 18161730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple oxidants and multiple mechanisms in cytochrome P450 catalysis.
    Coon MJ
    Biochem Biophys Res Commun; 2003 Dec; 312(1):163-8. PubMed ID: 14630036
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective dehydrogenation/oxygenation of 3-methylindole by cytochrome p450 enzymes.
    Lanza DL; Yost GS
    Drug Metab Dispos; 2001 Jul; 29(7):950-3. PubMed ID: 11408359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.